Phenylpiracetam
Fonturacetam · Phenotropil · Carphedon · Actitropil · 4-Phenylpiracetam · Fenotropil
Last updated
At a glance
Overview
Phenylpiracetam sits in a strange and useful niche: it's a racetam by chemistry, but it behaves like a mild, clean dopaminergic stimulant. A phenyl ring bolted onto the piracetam skeleton turns a subtle cholinergic nootropic into something you actually feel — sharper focus, motor drive, cold tolerance, and a willingness to grind through work or a heavy session without the jittery overhead of amphetamines or a loaded pre-workout.
That's why physique-focused users, grad students, knowledge workers, and occasional endurance athletes keep it in the drawer as an "as-needed" tool. 100–200 mg in the morning before an exam, a deadline, or a heavy lower day is where it shines — the (R)-enantiomer acts as a functional dopamine transporter inhibitor, which maps cleanly onto the subjective "I'm dialed in" experience people report.
"R-phenylpiracetam acts as a dopamine transporter inhibitor, showing pronounced neuroprotective and anti-inflammatory effects in vivo." — Zvejniece et al., 2020, Inflammopharmacology
The catch — and the thing most people get wrong — is tolerance. Run it daily and the magic fades inside a week. Run it 1–3×/week and it stays useful for months. Below we'll cover the dose ladder (100/200/300 mg), how to cycle it to dodge tolerance, stacking with caffeine/theanine and choline, a pre-workout protocol for heavy training days, side effects (sleep disruption is the big one), and the WADA status anyone in a tested sport needs to know about before they touch it.
How Phenylpiracetam works
Phenylpiracetam is piracetam with a phenyl ring grafted onto the pyrrolidinone core — a small structural change that makes the molecule dramatically more lipophilic, much more potent (active doses drop ~30× vs. piracetam), and pushes it across the line from "quiet cholinergic polish" into genuine stimulant territory. The result is a compound that feels closer to a mild amphetamine crossed with a racetam than to classical nootropics like aniracetam or oxiracetam.
Dopamine Transporter Inhibition#
The cleanest, best-characterized mechanism is DAT inhibition by the (R)-enantiomer. By blocking dopamine reuptake in striatal and cortical synapses, phenylpiracetam raises extracellular dopamine — which is the substrate for the locomotor activation, motivational "get up and move" quality, and the pre-workout drive users actually feel. It's also why the subjective profile resembles low-dose stimulants rather than piracetam.
"R-phenylpiracetam acts as a dopamine transporter inhibitor, showing pronounced neuroprotective and anti-inflammatory effects in vivo." — Zvejniece et al., Inflammopharmacology, 2020
Practically: this is the mechanism that makes it useful 45–60 min pre-training for heavy or technical sessions, and it's also the mechanism that bans it in-competition under WADA as "fonturacetam."
NMDA, Nicotinic, and GABA_A Receptor Upregulation#
Radioligand studies in rodent cortex and hippocampus show that repeated dosing increases the density of NMDA, nicotinic acetylcholine (nACh), and GABA_A binding sites. NMDA and nACh upregulation underpin the memory-consolidation and anti-amnestic effects (learning, recall under load); GABA_A changes likely contribute to the paradoxical "stimulated but not anxious" subjective profile that most users report at 100–200 mg.
"Phenylpiracetam is absorbed rapidly and almost completely from the gastrointestinal tract, penetrates the blood-brain barrier, and is not metabolized in the body." — Malykh & Sadaie, Drugs, 2010
For the reader: this is why phenylpiracetam is a genuinely useful "big day" cognitive tool, not just a stim — the focus is coupled to better encoding, not just arousal.
Anti-Amnestic, Anticonvulsant, and Anti-Asthenic Activity#
The original Soviet pharmacology work characterized phenylpiracetam as distinctly more activating than piracetam, with a specific anticonvulsant action piracetam lacks, reversal of diazepam-induced sedation, suppression of post-rotational nystagmus, and blockade of electroconvulsive retrograde amnesia.
"Phenylpiracetam exhibited pronounced activating, antiamnesic, and anticonvulsant properties in animal studies compared to piracetam." — Bobkov et al., Biull Eksp Biol Med, 1983
The anti-asthenic / anti-fatigue component — including the well-documented cold-tolerance effect — is the reason endurance athletes keep rediscovering this compound, and why it's useful for long training sessions, outdoor cardio in the cold, or grinding deadlines where fatigue is the bottleneck.
Cerebral Blood Flow and Neuroprotection#
Phenylpiracetam increases regional cerebral blood flow and improves tissue oxygen utilization under hypoxic conditions. This is the pharmacological basis of the Russian stroke-rehabilitation indication, where 200–400 mg/day over 30 days improved functional outcomes in post-stroke patients.
"Phenotropil administered at 200–400 mg daily improved neurological outcomes and functional status in stroke rehabilitation patients during a 30-day course." — Kovalchuk et al., Zh Nevrol Psikhiatr, 2010
Combined with the anti-inflammatory effects that ride along with DAT inhibition (Zvejniece 2020), this gives phenylpiracetam a modest neuroprotective profile on top of its acute stimulant action — relevant for users running long cycles of harder compounds and wanting something that isn't purely catabolic on neural tissue.
Pharmacokinetics That Shape the Protocol#
The mechanism picture only makes sense alongside the PK: ~100% oral bioavailability, T_max around 1 hour, half-life 3–5 hours, essentially no hepatic metabolism, and rapid BBB penetration thanks to the phenyl ring. Translated to practice:
| Feature | Implication for dosing |
|---|---|
| T_max ~1 h | Dose 45–60 min pre-training or pre-event |
| Half-life 3–5 h | Single AM dose covers a workday; redosing past early afternoon wrecks sleep |
| No hepatic metabolism | Minimal drug-interaction burden via CYPs; stacks cleanly with most AAS / peptide protocols |
| Rapid DAT-mediated tolerance | Treat as acute tool (1–3×/week), not a daily driver |
The tolerance point is the one most users get wrong. The DAT-inhibition and monoaminergic components downregulate quickly with consecutive daily dosing — subjective effect typically fades within 3–5 days and doesn't fully return on redose for weeks. Used intermittently at 100–200 mg on the mornings that actually matter (heavy training, exam, deadline, long drive, cold outdoor session), it's one of the more reliably felt compounds in the nootropic space. Used daily, it burns itself out inside a week.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 100–100 mg | As needed | Documented entry-level range |
| Mid | 100–200 mg | As needed | Most commonly studied range |
| High | 200–300 mg | As needed | Dose in the morning; a second dose can be added at 4–6 hours for long days. Do not dose past early afternoon — sleep disruption is the #1 side effect. Tolerance builds within 3–5 consecutive days, so treat this as an acute tool (1–3×/week), not a daily driver. |
Cycle length & outcomes
Documented cycle
1–4 weeks
Plateau after
2 wks
Cycle Structure#
Phenylpiracetam is not a compound you "cycle" in the AAS sense — it's an acute cognitive tool with a short half-life (3–5 hours) and a well-documented tolerance curve. The dominant mistake is treating it like a daily nootropic. Run it that way and the stimulant/euphoric effect attenuates within 3–5 days and often doesn't fully return on redose. Run it intermittently and it stays reliable for months.
"Phenylpiracetam is absorbed rapidly and almost completely from the gastrointestinal tract, penetrates the blood-brain barrier, and is not metabolized in the body." — Malykh & Sadaie, Drugs (2010)
The practical framework: pick a use-case, match the protocol, keep dosing days separated.
Protocol by Goal#
| Goal | Protocol Length | Dose | Frequency |
|---|---|---|---|
| "Big day" cognitive push (exam, deadline, comp) | Acute, single-use | 100–200 mg AM | 1–2×/week max |
| Pre-workout focus for heavy/technical sessions | Ongoing, intermittent | 100–200 mg, 45–60 min pre | 2–3 sessions/week, non-consecutive |
| Short stimulant-replacement block | 10–14 days max | 100–200 mg AM | Daily, then 2–4 week washout |
| Cold-weather / long endurance day | Acute | 100–200 mg AM | As needed |
| Post-TBI / stroke rehab (clinical) | 30 days, up to 3 courses/year | 200–400 mg split AM + early PM | Daily within course |
The 30-day daily protocol is the one with the largest clinical dataset, but it's also the context where tolerance is least relevant — you're not chasing a subjective stimulant feel, you're driving a recovery process.
"Phenotropil administered at 200–400 mg daily improved neurological outcomes and functional status in stroke rehabilitation patients during a 30-day course." — Kovalchuk et al., Zh Nevrol Psikhiatr (2010)
Onset, Loading, and Tapering#
- Onset: Sharp and unmistakable. T_max is ~1 hour; most users feel the shift within 30–45 minutes on an empty stomach. This is not a "stacks slowly over weeks" racetam — you'll know on dose one whether your batch is real.
- Loading: None required and none useful. Phenylpiracetam has ~100% oral bioavailability and isn't metabolized, so there's nothing to saturate.
- Tapering: Not required. No HPTA involvement, no receptor-downregulation rebound beyond the stimulant tolerance already discussed. Stopping cold after a 10–14 day block may produce 1–3 days of mild fatigue or flat mood as DAT activity normalizes — sleep it off.
- Washout between blocks: Minimum 2–4 weeks after any continuous run of 5+ days. For intermittent as-needed dosing (1–3×/week), no dedicated washout is needed.
Timing Within the Day#
Dose before noon, ideally on waking or pre-training. The 3–5 hour half-life is short on paper but the stimulant tail reliably disrupts sleep if dosed late. A second 100 mg at 4–6 hours is fine for long days; anything past ~2 pm is a bad trade. This is the single most common self-inflicted side effect.
Bloodwork and Monitoring#
No routine panel is required for intermittent use — phenylpiracetam is non-hormonal, non-hepatotoxic, and has no relevant lipid or metabolic footprint.
The one monitoring point worth flagging: if you're running it alongside an AAS cycle, include resting blood pressure and heart rate in your normal cycle checks. The DAT-inhibition mechanism produces a modest dose-dependent bump in both, which stacks additively with the cardiovascular load of orals or high-dose injectables.
"R-phenylpiracetam acts as a dopamine transporter inhibitor, showing pronounced neuroprotective and anti-inflammatory effects in vivo." — Zvejniece et al., Inflammopharmacology (2020)
Tested-Athlete Warning#
Non-negotiable, because the structure of this compound makes it trivially detectable:
"Phenylpiracetam (fonturacetam) is prohibited in competition by the World Anti-Doping Agency due to its stimulant and ergogenic properties." — Jędrejko et al., Drug Test Anal (2023)
Listed as fonturacetam / carphedon / 4-phenylpiracetam on the WADA Prohibited List (S6 stimulants, in-competition) since 1998. NCAA, USADA, tested federations, and most military drug panels will flag it. If you test, do not use — there's no masking strategy and the window is long relative to the short half-life because metabolite screens are sensitive.
Bottom Line#
Treat phenylpiracetam like a scalpel, not a daily vitamin: 100–200 mg, before noon, 1–3 days per week, with the occasional 10–14 day block when a finite project demands it. Used that way it's one of the more reliably-felt compounds in the nootropic space and stacks cleanly with caffeine + L-theanine for heavy training days or cognitively demanding work.
Risks & mistakes
Common (most users)#
- Insomnia / fragmented sleep — the #1 issue, and almost always self-inflicted by dosing too late. Keep all dosing before noon; for a second dose on a long day, cap it at early afternoon (by ~1–2pm) and keep it at 100mg.
- Mild headache or forehead pressure — typically in the first few hours after dosing. Add Alpha-GPC 300mg or CDP-choline 250mg with the dose, hydrate, and don't stack on top of a heavy caffeine load (>200mg).
- Irritability / edge — usually a dose issue. Drop from 200mg → 100mg; pair with L-theanine 100–200mg to smooth the stimulant feel.
- Next-day flatness / "come-down" — low-grade fatigue or dysphoria the day after a high-dose session. Sleep, food, and not dosing again for 2–3 days fixes it.
- Loss of effect within 3–5 days of daily use — not a true side effect but the defining practical limitation. Treat phenylpiracetam as an as-needed tool (1–3×/week), not a daily driver. Users who run it daily almost universally report the magic fades and doesn't fully return.
"Phenylpiracetam exhibited pronounced activating, antiamnesic, and anticonvulsant properties in animal studies compared to piracetam." — Bobkov et al., Biull Eksp Biol Med (1983)
Uncommon (dose-dependent or individual)#
- Mild tachycardia and BP bump — dose-dependent, more noticeable at 200–300mg and when stacked with caffeine or a strong pre-workout. If you're on cycle, include resting BP and HR in your normal monitoring on dose days. Back off to 100mg or skip dosing if resting BP is trending up.
- Jaw tension / bruxism — classic DAT-inhibitor signature. Reliable sign you're dosed too high; drop to 100mg.
- Anxiety / over-stimulation — more common in anxiety-prone users and with a double-dose day. L-theanine helps; if it doesn't, this isn't your compound.
- GI discomfort — uncommon, usually resolves by taking with food.
- Appetite suppression — mild and short-lived, follows the stimulant curve. Not a useful cut tool — don't try to use it this way.
"R-phenylpiracetam acts as a dopamine transporter inhibitor, showing pronounced neuroprotective and anti-inflammatory effects in vivo." — Zvejniece et al., Inflammopharmacology (2020)
Rare but serious#
- Hypertensive episodes — rare at label doses; real risk in users with untreated hypertension or when stacked with other sympathomimetics (high-dose clen, ephedrine, yohimbine, amphetamines). Warning signs: pounding headache, visual changes, chest pressure. Stop and check BP.
- Arrhythmia / palpitations — rare; if you get sustained irregular beats, stop and don't re-challenge.
- Serotonergic / dopaminergic interaction with MAOIs — mechanistically serious given the DAT action. Do not combine.
- Failed drug test — not a medical event but a career-ending one for tested athletes. Fonturacetam is WADA-prohibited in-competition as an S6 stimulant and is detectable for days to weeks after a single dose.
"Phenylpiracetam (fonturacetam) is prohibited in competition by the World Anti-Doping Agency due to its stimulant and ergogenic properties." — Jędrejko et al., Drug Test Anal (2023)
Hard contraindications#
- MAOIs — do not combine. DAT inhibition + MAO inhibition is a serious cardiovascular and serotonergic risk.
- Amphetamines, methylphenidate, cocaine, or other strong dopaminergic stimulants — do not stack. No additional cognitive benefit, substantial cardiovascular and sleep cost.
- Uncontrolled hypertension or known arrhythmia — do not use until the underlying issue is managed.
- Tested competition (WADA, USADA, NCAA, most combat sports, tested federations) — do not use in-competition, and respect the washout window before testing.
- Pregnancy and lactation — no adequate safety data. Do not use.
- Severe anxiety or panic disorder — a DAT inhibitor is the wrong tool.
Gender considerations and PCT#
Phenylpiracetam is non-hormonal. Women use the same 100–200mg dose range as men with no virilization risk and no menstrual-cycle concerns. It does not touch the HPTA, does not aromatize, and does not require PCT or any ancillary support — the only "ancillary" anyone reaches for is an optional choline source to blunt headaches. The only sex-specific rule is the standard one: avoid in pregnancy and lactation.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.10 | ×1.05 | ×1.12 |
FAQ — Phenylpiracetam
Research & citations
5 studies cited on this page.
Conclusion
Phenylpiracetam is a standout acute-focus nootropic for anyone needing a reliable boost in drive, focus, cold tolerance, or technical performance — as long as you respect tolerance and cycle it smartly.
Key takeaways:
- Standard dose: 100–200 mg oral, taken in the morning as-needed
- Redosing past early afternoon is a sure way to kill your sleep
- Use 1–3×/week, not daily — rapid tolerance is real and hard to reverse
- Pairs exceptionally well with 100–200 mg caffeine (+ optional L-theanine); avoid stacking with other strong stimulants or MAOIs
- Cycle length: keep runs to max 10–14 days if going consecutive, then take at least a 2–4 week break
- Best fit: big training days, exams, high-stakes events, endurance/cold-weather sessions — not a casual daily driver
If you want acute, stimulating cognitive enhancement that feels like a smoother, more functional alternative to amphetamines (with fewer downsides when dosed right), phenylpiracetam belongs in your toolkit. Use it intermittently, stack cleanly, and you get all the upside with minimal risk.